PTO- 1478 |
Approved for use through 10/31/2024. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 97563455 |
Filing Date: 08/24/2022 |
Input Field |
Entered |
SERIAL NUMBER | 97563455 |
---|---|
MARK INFORMATION | |
*MARK | ExCyte |
STANDARD CHARACTERS | YES |
USPTO-GENERATED IMAGE | YES |
LITERAL ELEMENT | ExCyte |
MARK STATEMENT | The mark consists of standard characters, without claim to any particular font style, size, or color. |
REGISTER | Principal |
APPLICANT INFORMATION | |
*OWNER OF MARK | Novoxa Biotech, Inc. |
DBA/AKA/TA/Formerly | DBA ExCyte |
*MAILING ADDRESS | 4625 West Nevso Drive STE 2 |
*CITY | Las Vegas |
*STATE (Required for U.S. applicants) |
Nevada |
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
*ZIP/POSTAL CODE (Required for U.S. and certain international addresses) |
89103 |
PHONE | 551-220-1533 |
*EMAIL ADDRESS | XXXX |
LEGAL ENTITY INFORMATION | |
TYPE | corporation |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION | Nevada |
GOODS AND/OR SERVICES AND BASIS INFORMATION | |
INTERNATIONAL CLASS | 042 |
*IDENTIFICATION | Research and development of new products |
FILING BASIS | SECTION 1(a) |
FIRST USE ANYWHERE DATE | At least as early as 01/20/2020 |
FIRST USE IN COMMERCE DATE | At least as early as 01/20/2020 |
SPECIMEN FILE NAME(S) | \\TICRS\EXPORT18\IMAGEOUT 18\975\634\97563455\xml1 \ APP0003.JPG |
SPECIMEN DESCRIPTION | NO DESCRIPTION ENTERED |
WEBPAGE URL | None Provided |
WEBPAGE DATE OF ACCESS | None Provided |
CORRESPONDENCE INFORMATION | |
NAME | Novoxa Biotech, Inc. |
DOCKET/REFERENCE NUMBER | Peyman3 |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | romeo.rac4@gmail.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | Hnelson@avirtuallawyer.com |
FEE INFORMATION | |
APPLICATION FILING OPTION | TEAS Standard |
NUMBER OF CLASSES | 1 |
APPLICATION FOR REGISTRATION PER CLASS | 350 |
*TOTAL FEES DUE | 350 |
*TOTAL FEES PAID | 350 |
SIGNATURE INFORMATION | |
SIGNATURE | /Novoxa Biotech, Inc./ |
SIGNATORY'S NAME | Novoxa Biotech, Inc. |
SIGNATORY'S POSITION | Business Entity |
SIGNATORY'S PHONE NUMBER | 551-220-1533 |
DATE SIGNED | 08/24/2022 |
SIGNATURE METHOD | Signed directly within the form |
PTO- 1478 |
Approved for use through 10/31/2024. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 97563455 |
Filing Date: 08/24/2022 |
The applicant's current Correspondence Information: |
Novoxa Biotech, Inc. |
PRIMARY EMAIL FOR CORRESPONDENCE: romeo.rac4@gmail.com SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): Hnelson@avirtuallawyer.com The docket/reference number is Peyman3. Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS). |
|
|